Table 2. Features of patients with CNS disease.
Patient | CNS Symptoms | CSF Flow cytometry / Cytology | Imaging at time of CNS disease |
---|---|---|---|
1 | None | Paucicellular cytospin specimen with rare atypical lymphocytes | CT head - Negative |
2 | None | CD4+, CD25+, CD7-, CD26- | CT head - Negative |
3 | Cranial nerve palsy | CD3 +, CD4+, CD25+, CD27+, CD7-, CD26- | MRI Brain - Diffuse dural thickening |
4 | None | CD2+, CD3+, CD4+, CD5+, CD7- | CT head - Negative |
5 | None | 23% CD4+ T-cells with reduced CD7 expression, partial expression of CD25 | CT head-Negative |
6 | None | Positive for malignant cells, | MRI head-Meningeal enhancement |
7 | None | Abnormal CD4+ T-cells that lack CD7 | CT Head - Negative |
8 | Headache | Positive for malignant cells | CT head-Right frontal skull lesion with dehiscence of the inner table, with a minimal epidural component |
9 | None | CD2+, CD3+, CD4+, CD5+, CD8+, CD7- | MRI Brain - Normal |
10 | None | CD4+, CD25+, CD7- phenotype | MRI Brain - Faint thin dural enhancement |
11 | None | CD4+, CD25+ T-cells | CT head - Negative |
12 | Headache | 0.6% CD3+, CD4+, CD7-, CD25+ T-cells | MRI Brain - Large destructive sinonasal mass, extension to adjacent structures. Parameningeal extension. |
13 | None | CD2+, CD7+, CD3+, CD5+, CD4-, CD8- | CT head - Negative |
14 | None | 9% T-cells CD4+, CD7-, mostly CD25+ | CT head - Negative |
15 | None | Atypical. Scattered lymphocytes, some with mild atypia. | CT head - Negative |
CNS: central nervous system; CSF: cerebral spinal fluid; CT: computed tomography; MRI: magnetic resonance imaging.
(n=15).